Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endocrinology and Metabolic Disease | Discovery | - | Neurogene, Inc. (New York)Startup | 04 Jan 2024 |
Endocrinology and Metabolic Disease | Discovery | - | 04 Jan 2024 | |
Immune System Diseases | Discovery | - | 04 Jan 2024 | |
Immune System Diseases | Discovery | - | Neurogene, Inc. (New York)Startup | 04 Jan 2024 |
Nervous System Diseases | Discovery | - | Neurogene, Inc. (New York)Startup | 04 Jan 2024 |
Nervous System Diseases | Discovery | - | 04 Jan 2024 | |
Skin and Musculoskeletal Diseases | Discovery | - | Neurogene, Inc. (New York)Startup | 04 Jan 2024 |
Skin and Musculoskeletal Diseases | Discovery | - | 04 Jan 2024 |